ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Salarius Pharmaceuticals Inc

Salarius Pharmaceuticals Inc (SLRX)

0,9531
0,0572
(6,38%)
Geschlossen 23 März 9:00PM
0,9202
-0,0329
(-3,45%)
Nach Börsenschluss: 12:59AM
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,9531
Gebot
0,9201
Fragen
0,95
Volumen
20.852
0,87 Tagesbereich 0,94
0,8319 52-Wochen-Bereich 7,20
Marktkapitalisierung
Handelsende
0,8959
Handelsbeginn
0,92
Letzte Trade
50
@
0.94
Letzter Handelszeitpunkt
Finanzvolumen
US$ 18.648
VWAP
0,894316
Durchschnittliches Volumen (3 Mio.)
2.392.419
Ausgegebene Aktien
1.441.157
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,11
Gewinn pro Aktie (EPS)
-8,7
Erlöse
-
Nettogewinn
-12,54M

Über Salarius Pharmaceuticals Inc

Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Salarius Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SLRX. The last closing price for Salarius Pharmaceuticals was US$0,90. Over the last year, Salarius Pharmaceuticals shares have traded in a share price range of US$ 0,8319 to US$ 7,20.

Salarius Pharmaceuticals currently has 1.441.157 shares in issue. The market capitalisation of Salarius Pharmaceuticals is US$1,29 million. Salarius Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.11.

SLRX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0369-3.727272727270.991.0020.8319238150.89840993CS
4-0.3969-29.41.351.670.83191760571.32646387CS
12-0.7014-42.39347234811.65457.20.831923924193.53172581CS
26-0.7369-43.60355029591.697.20.831912492473.27651982CS
52-3.7669-79.80720338984.727.20.831912566423.03466418CS
156-77.0469-98.77807692317888.80.831960173413.78960497CS
260-137.0469-99.30934782611387000.8319772839151.95395495CS

SLRX - Frequently Asked Questions (FAQ)

What is the current Salarius Pharmaceuticals share price?
The current share price of Salarius Pharmaceuticals is US$ 0,9531
How many Salarius Pharmaceuticals shares are in issue?
Salarius Pharmaceuticals has 1.441.157 shares in issue
What is the market cap of Salarius Pharmaceuticals?
The market capitalisation of Salarius Pharmaceuticals is USD 1,29M
What is the 1 year trading range for Salarius Pharmaceuticals share price?
Salarius Pharmaceuticals has traded in the range of US$ 0,8319 to US$ 7,20 during the past year
What is the PE ratio of Salarius Pharmaceuticals?
The price to earnings ratio of Salarius Pharmaceuticals is -0,11
What is the reporting currency for Salarius Pharmaceuticals?
Salarius Pharmaceuticals reports financial results in USD
What is the latest annual profit for Salarius Pharmaceuticals?
The latest annual profit of Salarius Pharmaceuticals is USD -12,54M
What is the registered address of Salarius Pharmaceuticals?
The registered address for Salarius Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Salarius Pharmaceuticals website address?
The website address for Salarius Pharmaceuticals is www.flex-pharma.com
Which industry sector does Salarius Pharmaceuticals operate in?
Salarius Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SGLYSingularity Future Technology Ltd
US$ 1,6799
(143,43%)
30,76M
WINVWinVest Acquisition Corporation
US$ 25,00
(107,30%)
463
VVPRVivoPower International PLC
US$ 1,2899
(52,13%)
65,08M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
GLTOGalecto Inc
US$ 6,00
(44,93%)
10,71M
YHCLQR House Inc
US$ 0,40
(-82,38%)
38,32M
KZIAKazia Therapeutics Ltd
US$ 0,9759
(-80,02%)
55,66k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
TCBPTC BioPharm Holdings PLC
US$ 0,5046
(-67,23%)
5,9M
SOWGSow Good Inc
US$ 1,53
(-44,36%)
698,02k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
NVDANVIDIA Corporation
US$ 117,70
(-0,70%)
264,42M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,03
(10,66%)
175,77M
HOLOMicroCloud Hologram Inc
US$ 1,00
(32,36%)
141,98M

SLRX Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock